Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.378ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.378ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.378NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.206ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.206ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.206ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.206NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.77ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.77NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.13.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.13.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBEORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBEENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBEENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBENUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used